CPG Immunopharmaceuticals GmbH
Records under this name other than patents CPG Immunopharmaceuticals GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to CPG Immunopharmaceuticals GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,202,688 | Use of Nucleic Acids Containing Unmethylated CPG Dinucleotide as an Adjuvant Formerly held Term ended Term ended Mar 3, 2020 · Medium confidence | Term ended | Term ended Mar 3, 2020 | Medium confidence |
| US 7,488,490 | Method of Inducing an Antigen-Specific Immune Response by Administering a Synergistic Combination of Adjuvants Comprising Unmethylated Cpg-Containing Nucleic Acids and a Non-Nucleic Acid Adjuvant. Formerly held Term ended Term ended Mar 10, 2018 · Medium confidence | Term ended | Term ended Mar 10, 2018 | Medium confidence |
| US 6,406,705 | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant Formerly held Lapsed on the fee record Ended Jun 18, 2014 · USPTO record | Lapsed on the fee record | Ended Jun 18, 2014 | USPTO record |
| US 7,001,890 | Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination Formerly held Lapsed on the fee record Ended Feb 21, 2014 · USPTO record | Lapsed on the fee record | Ended Feb 21, 2014 | USPTO record |
| US 6,339,068 | Vectors and methods for immunization or therapeutic protocols Formerly held Lapsed on the fee record Ended Jan 15, 2014 · USPTO record | Lapsed on the fee record | Ended Jan 15, 2014 | USPTO record |